5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 4.30▲ | 4.30▲ | 4.29▲ | 4.18▲ | 3.65▲ |
MA10 | 4.28▲ | 4.28▲ | 4.29▲ | 3.93▲ | 2.96▲ |
MA20 | 4.29▲ | 4.30▲ | 4.27▲ | 3.43▲ | 3.63▲ |
MA50 | 4.29▲ | 4.21▲ | 4.04▲ | 2.79▲ | 4.65▼ |
MA100 | 4.31▲ | 4.01▲ | 3.61▲ | 3.94▲ | 4.31▲ |
MA200 | 4.28▲ | 3.55▲ | 3.06▲ | 4.57▼ | 5.36▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.004▲ | -0.010▼ | -0.022▼ | 0.098▲ | 0.204▲ |
RSI | 55.082▲ | 53.843▲ | 57.569▲ | 79.469▲ | 54.188▲ |
STOCH | 76.929 | 58.255 | 50.000 | 90.016▲ | 87.346▲ |
WILL %R | -12.500▲ | -36.066 | -36.066 | -7.432▲ | -3.887▲ |
CCI | 98.217 | 9.913 | -33.956 | 101.547▲ | 178.559▲ |
Monday, July 07, 2025 04:45 PM
Alexander & Baldwin, Inc. (NYSE: ALEX) ("A&B" or "Company"), a Hawai'i-based owner, operator, and developer of high-quality commercial real estate in Hawai'i, will report results for the second ...
|
Wednesday, July 02, 2025 06:23 PM
Aldeyra's Reproxalap progresses towards FDA approval, with a potential $100M AbbVie deal. There’s still upside potential, which is why ALDX is buy rated. See more.
|
Friday, June 27, 2025 05:00 PM
Find the latest on short interest, settlement dates, average share volume, and days to cover for Aldeyra Therapeutics, Inc. Common Stock (ALDX) at Nasdaq.com.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
08/07/25 | 4.39 | 4.43 | 4.125 | 4.32 | 1,025,581 |
07/07/25 | 4.26 | 4.43 | 4.164 | 4.35 | 906,900 |
03/07/25 | 4.02 | 4.335 | 4.00 | 4.30 | 757,113 |
02/07/25 | 3.98 | 4.21 | 3.94 | 4.00 | 1,504,630 |
01/07/25 | 3.79 | 4.035 | 3.73 | 3.93 | 922,977 |
30/06/25 | 3.82 | 3.975 | 3.675 | 3.83 | 1,514,090 |
27/06/25 | 3.97 | 3.995 | 3.735 | 3.79 | 2,539,460 |
26/06/25 | 3.68 | 3.93 | 3.515 | 3.87 | 1,958,083 |
25/06/25 | 3.34 | 3.64 | 3.29 | 3.51 | 1,248,502 |
24/06/25 | 3.079 | 3.37 | 3.00 | 3.35 | 685,227 |
|
|
||||
|
|
||||
|
|